Annette F. Favorite - Aug 30, 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Sr. VP & Chief HR Officer
Signature
Ryan Metz as Agent for Annette F. Favorite
Stock symbol
WST
Transactions as of
Aug 30, 2023
Transactions value $
-$662,337
Form type
4
Date filed
9/1/2023, 03:46 PM
Previous filing
May 2, 2023
Next filing
Dec 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $167K +2K +13.44% $83.47* 16.9K Aug 30, 2023 Direct
transaction WST Common Stock Sale -$315K -760 -4.5% $414.20 16.1K Aug 30, 2023 Direct F1
transaction WST Common Stock Sale -$514K -1.24K -7.69% $414.91 14.9K Aug 30, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to buy) Options Exercise $0 -2K -19.14% $0.00 8.45K Aug 30, 2023 Common Stock 2K $83.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 This option is fully vested.